Drug Targeting and Design
A section of Pharmaceutics (ISSN 1999-4923).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- New Pharmaceutical Targets to Counteract Chronic Inflammation (Deadline: 20 April 2024)
- Ultrasound Assisted in Tumor Immunotherapy (Deadline: 20 April 2024)
- Recent Advances in the Development of Hybrid Drugs (Deadline: 20 April 2024)
- Pharmaceutical Applications of Metal Complexes and Derived Materials (Deadline: 20 April 2024)
- New Discoveries in Drug Targets and Delivery for Alzheimer’s Disease (Deadline: 25 April 2024)
- Theranostic Radiopharmaceuticals: Current Status and Perspectives (Deadline: 30 April 2024)
- Novel Drugs, Targets and Therapies against Infectious Diseases (Deadline: 30 April 2024)
- Emerging Pharmaceutical Therapeutics for Neglected Tropical Diseases (Deadline: 30 April 2024)
- Cancer Therapy Resistance: Choosing Kinase Inhibitors, 2nd Edition (Deadline: 30 April 2024)
- Ultrasound in Anticancer and Antimicrobial Therapy (Deadline: 10 May 2024)
- Emerging Pharmaceutical Strategies against Infectious Diseases (Deadline: 10 May 2024)
- Current and Future Cancer Chemoprevention Strategies, 2nd Edition (Deadline: 20 May 2024)
- Computer-Aided Development: Recent Advances and Expectations (Deadline: 20 May 2024)
- Nanozymes for Anti-cancer and Anti-bacterial Treatment (Deadline: 20 May 2024)
- Studies on the Cytotoxicity and Antimicrobial Effects of Synthetic and Natural Compounds (Deadline: 20 May 2024)
- State of the Art of Membrane Active Peptides, 2nd Edition (Deadline: 30 May 2024)
- Research on the Design of New Metal-Based Antitumor Drugs (Deadline: 31 May 2024)
- Predicting ADME: Role of Computer-Aided Drug Design (Deadline: 31 May 2024)
- Photodynamic Therapy: Recent Progress and Development (Deadline: 31 May 2024)
- Prodrugs and Molecular Hybrids as Innovative Strategies in Medicinal Chemistry (Deadline: 10 June 2024)
- Application Prospect of Hydrogels in the Treatment of Osteochondral Lesions (Deadline: 20 June 2024)
- Where Are We Now and Where Is Antimicrobial Therapy Headed? (Deadline: 20 June 2024)
- Novel Technological Approaches for Targeted Drug Delivery Systems (Deadline: 20 June 2024)
- Recent Advances in the Prevention and Eradication Strategies for Combating Biofilm-Related Infections (Deadline: 20 June 2024)
- Next-Generation Antibody-Drug Conjugates (ADCs) (Deadline: 20 June 2024)
- Alternative Model-Based Translational Drug Development (Deadline: 25 June 2024)
- Drugs and Drug Delivery for Diabetes Mellitus Treatment, 2nd Edition (Deadline: 30 June 2024)
- Drug Targeting for CNS Disease, 2nd Edition (Deadline: 30 June 2024)
- Progress in Photoactive Biomaterial-Based Synergistic Combination Phototherapy (Deadline: 1 July 2024)
- Advanced Nanopharmaceutics for Anticancer Therapy (Deadline: 15 July 2024)
- Combination of Targeted Radiotherapy with Other Therapeutic Modalities for Cancer Treatment (Deadline: 20 July 2024)
- Novel Therapeutic Approaches for the Treatment of Neurodegenerative Diseases (Deadline: 20 July 2024)
- Natural Products in Photodynamic Therapy (Deadline: 20 July 2024)
- Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition (Deadline: 30 July 2024)
- Research on Porphyrin Compounds Used in Photodynamic Anticancer and Antimicrobial Therapy (Deadline: 31 July 2024)
- Metallodrugs in Cancer Therapy: The Newest Candidates in the Field, 2nd Edition (Deadline: 31 July 2024)
- Recent Advances in Radiopharmaceutics, 2nd Edition (Deadline: 10 August 2024)
- Promising Small Molecule Compounds in Cancer Treatment (Deadline: 10 August 2024)
- Research on Radiotracers and Novel Radiopharmaceuticals for Cancer Therapy and Diagnosis (Deadline: 10 August 2024)
- Brain Tumors Treatment: Current and Future Challenges from Drug Formulations to Delivery Methods (Deadline: 16 August 2024)
- Photodynamic Therapy in Cancer: Principles, State of the Art, and Future Directions (Deadline: 20 August 2024)
- Antiviral and Antibacterial: Focus on Novel Therapeutic Agents and Drug Delivery Systems (Deadline: 20 August 2024)
- Molecular Imaging of the Immune System (Deadline: 30 August 2024)
- Tropical Protozoan Disease Treatment Drugs (Deadline: 31 August 2024)
- Combination Therapy Approaches for Cancer Treatment (Deadline: 31 August 2024)
- Novel Radiopharmaceuticals for Theranostic Applications (Deadline: 31 August 2024)
- Uncovering the Newest Research in Antiviral-Drugs Development and Potential of Combined Therapy (Deadline: 10 September 2024)
- New Insights into Targeted Therapy of Solid Tumors with Polymeric Nanoparticles (Deadline: 10 September 2024)
- Therapeutic Approaches for Wound-Associated Skin Diseases (Deadline: 20 September 2024)
- The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs (Deadline: 20 September 2024)
- Bioactive Agents for the Treatment against Tuberculosis (Deadline: 20 September 2024)
- Diabetes Mellitus: Promising Molecules, Drug Modification, Formulations, and Therapy (Deadline: 20 September 2024)
- Serpins: Therapeutic Targets for Various Diseases (Deadline: 20 September 2024)
- Recent Advances in Therapeutic Strategies for the Treatment of Pediatric Diseases (Deadline: 24 September 2024)
- Novel Pharmaceuticals Development and Delivery Systems for the Treatment of Parasitic Diseases, 2nd Edition (Deadline: 30 September 2024)
- Natural Products for Antimicrobial and Drug Delivery: A Look into the Future (Deadline: 30 September 2024)
- Research on the Design and Development of Infectious, Inflammatory and Cancer Therapeutics (Deadline: 30 September 2024)
- Novel Therapeutic Approach to Inflammation and Pain (Deadline: 30 September 2024)
- Kinase Inhibitor for Cancer Therapy, 2nd Edition (Deadline: 30 September 2024)
- Self-Assembled Amphiphilic Copolymers in Drug Delivery, 2nd Edition (Deadline: 15 October 2024)
- Nucleic-Acid-Based Strategies and Nanotechnology Applications for Targeted Therapy (Deadline: 20 October 2024)
- The State-of-the-art in Improving the Antitumor Efficacy of Platinum Drugs (Deadline: 20 October 2024)
- Advances in Anticancer Agent, 2nd Edition (Deadline: 31 October 2024)